Who founded Immuno Cancer Biotherapeutics?

Immuno Cancer Biotherapeutics was founded by James Robl (Co-founder, President and CSO).

Where is Immuno Cancer Biotherapeutics based?

Immuno Cancer Biotherapeutics is based in Canton, United States.

Immuno Cancer Biotherapeutics

Immuno Cancer Biotherapeutics is developing polyclonal antibody based therapies to target and overcome cancer heterogeneity and resistance.

Health and bio Consumer and social

Latest funding

Seed · October 15, 2026

Amount not disclosed in a source on record.

Funding history ↓

Website: icbiothera.com.

Categories: Health and bio Consumer and social.

Sectors: Biotechnology, Health Care, Therapeutics, Wellness.

Stage: Seed.

Based in: Canton, United States.

Last round: Oct 15, 2026 · 8 days ago.

Domain age: 2 years.

On Recent Funding since: Oct 17, 2026.

About Immuno Cancer Biotherapeutics

Immuno Cancer Biotherapeutics is a company based in Canton, United States. Recent Funding lists it under Health and bio (also Consumer and social). Its latest known round is a Seed round (October 2026); no sourced amount is on record for it yet. It was founded by James Robl.

Funding rounds

October 15, 2026
Seed · amount undisclosed
Source: sec.gov
July 1, 2024
Website created

Founders and team

JR
James Robl Co-founder, President and CSO

source: icbiothera.com

Similar Health and bio companies

HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026

Questions and sources

Immuno Cancer Biotherapeutics: questions and answers

Who founded Immuno Cancer Biotherapeutics?: Immuno Cancer Biotherapeutics was founded by James Robl (Co-founder, President and CSO).
Where is Immuno Cancer Biotherapeutics based?: Immuno Cancer Biotherapeutics is based in Canton, United States.

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/immuno-cancer-biotherapeutics (get a free API key).